J67.6
Maple-bark-stripper's lung
Clinical Classification Guidelines
Inclusion Terms
- Alveolitis due to Cryptostroma corticale
- Cryptostromosis
Medical Intelligence & Overview
Maple-bark-stripper's lung, also known as cryptostromosis, is a specific type of lung inflammation caused by inhaling spores from the fungus Cryptostroma corticale. This condition primarily affects individuals who work closely with maple trees, especially during certain forestry or wood-removal activities. Known under the ICD-10 code J67.6, it is classified as alveolitis due to Cryptostroma corticale. Recognizing the causes and symptoms can help in early identification and management of this occupational lung disease.
Causes & Symptoms
Clinical Causes: Inhalation of spores from Cryptostroma corticale fungus present on freshly cut or decaying maple bark. Prolonged and repeated exposure to contaminated wood dust in forestry, woodworking, or bark stripping activities. Working in damp or humid environments where the fungus thrives on wood surfaces. Increased risk during peak spore release seasons when fungal growth is abundant.
Key Symptoms: Persistent cough that may produce sputum Shortness of breath or difficulty breathing, especially after exertion Fever and chills in some cases Fatigue and general malaise Chest discomfort or tightness Wheezing or unusual breath sounds
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of occupational history assessment, clinical examination, and diagnostic tests. Lung function tests may reveal decreased lung capacity or airflow obstruction. Imaging techniques such as chest X-rays or CT scans can show inflammatory changes or infiltrates in the lungs. In some cases, a biopsy or sputum analysis may be conducted to identify Cryptostroma corticale spores or confirm alveolitis related to fungal exposure.
Treatment Protocols: Management of cryptostromosis involves eliminating exposure to the source of spores, which may include improving ventilation, using protective respiratory equipment, or changing work practices. Medical treatment may involve corticosteroids to reduce lung inflammation and supportive therapies such as oxygen supplementation for severe cases. Early intervention and removal from exposure are critical for preventing long-term lung damage.
Clinical Advice & FAQs
Billing Guidance
Is J67.6 a billable ICD-10 code?
Yes, J67.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J67.6?
Clinical documentation must specify the nature of Maple-bark-stripper's lung and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
